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ABSTRACT
Stem cells are unique in that they possess totipotent, pluripotent, or multipotent
differentiation capabilities and can also self-renew. Stem cells are in either a state of selfrenewal or differentiation, but never both. If we are able to gain a full understanding of the
underlying mechanisms that allow stem cells to remain self-renewing and multipotent, we
will better be able to control the fate of cells, ultimately allowing stem cells to be used to
their full capabilities in regenerative medicine. My research focuses on MED12 and its
effects on Notch signaling. Here we describe the expression profile and activity of MED12,
Notch1, and Notch3 in self-renewing human adipose stem cells and determine the impact
that MED12 knockdown has on Notch1 and Notch3 expression and activity in self
renewing hASC’s. We hypothesized that MED12 has a critical role in regulating
transcription, while Notch signaling has a role in directing cell fate commitment. We
observed that the knockdown of MED12 in hASCs has no effect on the protein expression
of Notch1. We also observed that the knockdown of Notch3 does reduce the amount of
MED12 transcript expressed in hASCs. To date, our data suggests that MED12 has no
effect on Notch1 expression but does affect Notch3 expression. Also, the knockdown of
Notch3 directly effects MED12 transcript. This data indicates a unique role for MED12
and a relationship with Notch3 in regulating cell state, leading us one step closer to
realizing the clinical potential of these cells and using them in novel cell-based and tissue
engineering therapies.
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CHAPTER 1
INTRODUCTION

1.1

Stem Cells
Stem cells are unique in that they possess totipotent, pluripotent, or multipotent

differentiation capabilities and can also self-renew (Miana and Prieto González, 2018).
Totipotent stem cells (zygote) have the ability to differentiate into any cell in the body as
well as extra embryonic tissues, including placenta (Sobhani et al., 2017). Pluripotent stem
cells (embryonic stem cells and induced pluripotent stem cells) have the same abilities to
form an adult organism but unlike totipotent stem cells, lack the ability to form extra
embryonic tissue (Sobhani et al., 2017). Multipotent stem cells (i.e adult stem cells) are the
most limited of the three types of stem cells, as they can only differentiate into cells of a
defined lineage (Sobhani et al., 2017). Although most limited in their differentiation
potential, multipotent adult stem cells possess the most therapeutic potential as they can be
used in an autologous manner and offer unique immunomodulatory properties in additional
to their differentiation potential.
Mesenchymal stem cells have the ability to differentiate into multiple cell types of
the mesodermal lineage such as osteocytes, chondrocytes, myocytes, and adipocytes
(Daniel E Shumer, Natalie J Nokoff, 2017) (Figure 1-1). Human mesenchymal stem cells
are found in bone marrow, adipose tissue, amniotic fluid, and the umbilical cord (NITKIN
and BONFIEL, 2014). In addition to the range of tissues from which these cells can be
1
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isolated, they are also not accompanied by the public controversies that are associated with
embryonic stem cells, making them a more acceptable source for research and clinical
application. When using these cells for regenerative medicine, bone marrow-derived
mesenchymal stem cells have been at the forefront of current studies due to their long
history of clinical usage in the form of bone marrow transplants (Sobhani et al., 2017).
Despite their clinical advantages, in order to obtain human bone marrow-derived
mesenchymal stem cells, an invasive and sometimes painful procedure needs to be
performed, making them a challenging cell source for additional therapeutic usage.
Human adipose stem cells offer an alternative to bone marrow-derived
mesenchymal stem cells that are both easily accessible and abundant using minimally
invasive procedures (Miana and Prieto González, 2018). Offering much of the same
clinical potential as bone marrow-derived cells, adipose stem cells are derived from adipose
tissue through subcutaneous lipoaspiration, a less invasive and less painful harvesting
protocol. Human adipose stem cells are currently being used in cancer treatment centers
and in multiple clinical trials. The clinical trials include attempts to repopulate areas of the
cardiac muscle after a heart attack in both animal models and humans and using the
multipotency of hASC’s as a regenerative treatment to counteract different conditions such
as such as coronary disease, osteoporosis, bone regeneration of the jaw (Miana and Prieto
González, 2018).

3

Figure 1-1: Gene expression is controlled by a complex regulatory network.
Environmental stimuli initially activate signal transduction pathways. Once signaling
components are activated, they can directly affect transcription factors and chromatin
modifiers to initiate or inhibit transcription. When a gene is transcribed, transcription
factors are activated and translocated into the nucleus of a cell to initiate transcription. If a
gene target is repressed, chromatin is modified and condensed to prevent transcription.
1.1.1

Notch Signaling
The Notch signaling pathway is an evolutionarily conserved cell fate determination

pathway that controls cell differentiation, proliferation, and apoptosis (Nueda et al., 2018).
The evolutionary conserved Notch signaling pathway functions as a mediator of shortrange cell-cell communication (Kopan and Ilagan, 2009). The ectodomain of a Notch
receptor can read information about the state of neighboring cells as it recognizes ligands
that are expressed at their surface, whereas its intracellular domain, upon activation, acts
as a transcriptional regulator that adjusts cell fate according to the state of the neighboring
cells (Henrique and Schweisguth, 2019).
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The Notch signaling pathway in humans consists of five canonical transmembrane
Notch ligands Delta-like ligand 1 (DLL1), DLL3, DLL4, Jagged 1, Jagged 2, and four
transmembrane Notch receptors: Notch1, Notch2, Notch3, and Notch4 (Nueda et al.,
2018). Each Notch receptor has three functional domains: The Notch extracellular domain,
the Notch transmembrane domain, and the Notch intracellular domain (NICD). Finally,
there are two forms of the Notch signaling pathway: the NICD /CSL‑dependent
transcription of Notch target genes known as the canonical Notch signaling cascade, and
the CSL‑independent cellular responses, referred to as the non‑canonical Notch signaling
cascade. The multiple components of the pathway and the different signaling mechanisms
make this one of the more complex biological pathways (Katoh and Katoh, 2020).
The Notch signaling pathway directly couples events at the cell membrane with the
regulation of transcription. Through the canonical pathway, receptors on a given cell are
activated in a contact dependent manner by cell surface ligands (Jagged1-2, DLL1, DLL3,
DLL4) from neighboring cells in a process known as trans-activation. Although ligands
expressed by neighboring cells have a trans-activation ability, ligands expressed in cis may
have an inhibitory function, which acts to maintain the state of the signal-sending cell,
keeping them from becoming signal-receiving cells. Once trans-activation is initiated, it
leads to a structural change in the Notch receptor that exposes the buried cleavage site (S2)
making it available to the metalloproteases of the ADAM/TACE family. Cleavage at this
S2 site then generates a membrane-tethered form of Notch that is further cleaved by γsecretase complex to release the Notch intracellular domain (NICD). The NICD is then
translocated to the nucleus to activate gene transcription (Figure 1-2). Notch has been
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confirmed to have a role in human development and disease making it a significant factor
in the study of stem cells and determination of cell fate (Henrique and Schweisguth, 2019).
Stem cells are able to both clone themselves (self-renew) or differentiate into
multiple cell types depending on how gene expression is regulated. Stem cell fate can be
regulated by altering the function and expression of the general transcription factors
(GTFs) that assemble the transcription preinitiation complex (PIC) on gene promoters.
GTFs also assemble activators and repressors that bind to gene regulatory elements located
upstream or downstream of promoters, and the essential coactivator of cell type-specific
genes like the Mediator complex. The fate of any stem cell is ultimately determined by
regulating the transcription of specific genes, a feature largely facilitated by the Mediator
complex (Straub, Venigalla and Newman, 2020).

Figure 1-2: Notch signaling pathway
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1.1.2

Mediator Complex
The Mediator complex plays a vital role in the regulation of cell-type specific

transcription in eukaryotic cells. The Mediator complex is a large protein complex of 30
subunits arranged in four modules: head, middle, tail, and kinase (CDK8) (Figure 1-3)
(Park et al., 2018). The head and middle modules contain the most highly conserved
subunits and maintain cell viability and overall gene expression, while the tail recruit’s
specific transcription factors to direct and maintain lineage commitment. Indicative of its
functional versatility, Mediator is implicated in regulating at least some aspect of many
fundamental processes involved in transcription, including transcription initiation,
transcription elongation, chromatin architecture and enhancer-promoter gene looping
(Allen and Taatjes, 2015). In the Mediator complex, CDK8 attaches to Mediator core
complex and activates or suppresses transcription via RNA polymerase II (Park et al.,
2018). The kinase module also functions independently of the Mediator complex. RNAPII,
TFIIH, histone H3, and MED13 have all been listed as substrates for the CDK8 kinase
(Knuesel et al., 2009). CDK8 is considered both an oncogene and a tumor suppressor and
promotes cell growth via the serum response pathway (Fant and Taatjes, 2019). In stem
cells, Mediator is the factor that controls regulation of transcription and in controlling
transcription, Mediator controls the fate of stem cells. CDK8 is a part of the 30 subunit
Mediator (MED) complex, which acts as a molecular bridge to mediate transduction of
regulatory signals (Leach and Leach, 2017). It completes this task by using a module that
consists of Cyclin C, Med12, and Med13. The Mediator complex is composed of multiple
important factors that are necessary for the regulation of transcription in eukaryotic cells
(Figure 1-1).

7

Figure 1-3: The Mediator complex

1.1.3

Motivation
Stem cells are in either a state of self-renewal or differentiation, but never at the

same time. If we are able to gain a full understanding of the underlying mechanisms that
allow stem cells to remain self-renewing and multipotent, we will better be able to control
the fate of cells, which is the key to regenerative medicine becoming a reality. With
conditions such as degenerative eye disease, stem cell treatment has the potential to replace
lost neurons, restore neural circuits, and even induce the growth of new connections in the
eye’s neural pathways (Mead et al., 2015). If we can extend this to other conditions like
Muscular dystrophies (MD) and Parkinson’s disease, we will be able to make a significant
change to the medical world by not only stopping the effects of these degenerative diseases,
but also reversing the damage that the disease has already caused.
The central dogma of molecular biology describes the process of transcribing DNA
to RNA and translating RNA to proteins. Transcription is a vital process in all living cells
and is ultimately what determines the fate of a cell. If we can gain an understanding of the
mechanisms surrounding transcriptional regulation in adipose stem cells, we can control
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the fate of the cell to stop stem cells from becoming cancerous and direct their fate for use
in cell-based therapies, tissue engineering, and regenerative medicine.
Both Mediator and the Notch signaling pathway work in unison to control the fate
of ASCs through the careful regulation of gene expression. Although critical to controlling
healthy tissue, the relationship between Mediator and Notch remains poorly defined. A
recent study suggests a possible influence of MED12 on Notch signaling in chronic
lymphocytic leukemia cells (Wu et al., 2017) found that in order to activate or repress
transcription, CDK8 is recruited to the MED12 subunit. Once in place, CDK8 interacts
with the rest of the kinase module, Cyclin C, MED12, and MED13, causing the complex
to activate or suppress transcription by RNA Polymerase II. In this study, MED12 effects
Notch signaling by functioning as an activator of Cyclin C/CDK8. If MED12 is mutated
or absent, it does not interact with the CDK8 kinase and the Notch Intracellular Domain
(NICD) is not phosphorylated, leading to an increase in Notch activity and transcription
activation. This aberrant regulation and absence of control leads to the activation of Notch,
which causes uncontrolled cell differentiation or proliferation. This recent report indicates
the need for further investigation in order to better understand the interaction and
relationship of these proteins in controlling hASC self-renewal and move stem cell research
and clinical application forward.

CHAPTER 2
METHODS

2.1
2.1.1

Cell culture
Thawing of cells.
Human adipose stem cells (Obatala #70926) were removed from liquid nitrogen

and thawed in a 37˚C water bath. Cells were transferred into a 15 mL conical containing
4mL of pre-warmed Complete Culture Media (CCM) composed of 203.75mL of Minimum
Essential Medium, 41.25mL of Fetal Bovine Serum, 2.5mL of L-Glutamine, and 2.5mL of
Penicillin-Streptomycin. Cells were centrifuged at 1500 RPM for 8 minutes. The
supernatant was removed, and cells were resuspended in 1mL of CCM. Cells were plated
the cells onto 10cm tissue culture plates with 9mL of CCM. Media was changed 24 hours
after the initial thaw, and every 48 hours after until cell confluency reached 70-80%.
2.1.2

Passaging of cells.
When the cells reached 70-80% confluence they were rinsed with pre-warmed

phosphate buffered saline (PBS). 3mL of Trypsin was added to the plate and cells were
incubated for 3 minutes at 37˚C. 6mL of CCM (or double the amount of trypsin) was then
added to the plate and the cells were collected into a conical tube for centrifugation at 1500
RPM for 10 minutes. Supernatant was aspirated and cells were resuspended in 1mL of prewarmed CCM. Cells were counted by mixing 20µL of trypan blue and 20µL of the cell
solution. Once mixed, 10µL of the cell-trypan solution was added onto both sides of the
9
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FL hemocytometer and the slide was inserted into the cell counter. After cells were
counted, they were then passaged onto 6cm plates. (Table 2-1)

Table 2-1: Number of cells plated onto each plate.
Plate size

Number of cells seeded

10cm plate

100,000 cells

6cm plate

45,000 cells

6-well plate

20,000 cells per well

2.1.3

Transfection of cells.
When the cells reached 20-40% confluency they were transfected with a control

siRNA or a target gene siRNA. Cells were transfected using RNAi Max Lipofectamine
following manufacturer’s protocol. Cells were incubated at 37˚C overnight and the next
day media was replaced with pre-warmed CCM. Media was changed 24 hours after the
transfection using CCM and RNA or protein was collected 72 hours after the transfection.
2.2
2.2.1

RNA
RNA collection.
72 hours after the transfection, plates were rinsed with PBS and RNA was collected

in 500µL of Trizol /6cm plate. Plates were gently scraped using a cell scraper and the
solution was collected and stored in a -80˚C freezer.
2.2.2

RNA extraction.
Trizol samples was thawed at room temperature and 100µL of chloroform was

added to each RNA sample. Each sample was then vortexed for 15 seconds and left to
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incubate at room temperature for 3 minutes. Once the incubation was complete, the samples
were centrifuged at 4˚C at 12000G and the colorless aqueous supernatant was removed and
placed into a new Eppendorf tube. 5µL of glycogen along with 250µL of 100% isopropyl
was added to each sample and each tube was inverted 3 times before it was left to incubate
at room temperature for 10 minutes. Samples were then centrifuged at 4˚C at 12000G for
10 minutes. The liquid supernatant was removed leaving only the RNA pellet. 1mL of 75%
ethanol was added to the pellet and then vortexed to wash the pellet. The samples were
then centrifuged for 5 minutes at 4˚C at 7500G. After the samples were centrifuged, the
liquid supernatant was removed and the pellet was allowed to air dry, before 30µL of
nuclease free water was added to RNA pellet. RNA was quantified to assess concentration
and purity using the BioTek plate reader. The Gen5 Microplate Reader and Imager
Software was used to analyze the data.
2.2.3

cDNA synthesis
cDNA was synthesized for each sample using 1 g of RNA and qScript cDNA

supermix following manufacturer protocol.
2.3

2.3.1

RT-PCR

Endpoint RT-PCR.

Primers (Table 2-2) and quality of cDNA were confirmed by endpoint RT-PCR using
GoTaq following manufacturer’s protocols.
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Table 2-2: Primer list
Gene

Forward Sequence

Reverse Sequence

Product size Temperature
(bp)

Cycles

MED12

CGAAAAGGGA
CAGCAGAAAC

CCCATCCTCCC
CACCTAAGA

87

60

30

Notch12

CACGCTGACG
GAGTACAAGT

GGCACGATTTC
CCTGACCA

56

60

35

Notch3

CACCCTTACCT
GACCCCATCC

TTCGGACCAGT
CTGAGAGGGA

81

60

35

Jagged1

GGCACGCGTC
ATTGTGTTAC

TGCGCAGCCTT
TTATTCCCT

119

60

35

Jagged2

TGGACGCCAAT
GAGTGTGAA

CCCGGGATGC
AATCACAGTA

91

60

35

DLL-1

CAGCAAGCGT
GACACCAAG

CTTTCAGATGC
TTCTCCACCCC

93

60

35

DLL-3

GTCCGAGCTCG
TCCGTAGA

AAAAGGGGCG
TCGCTACC

109

60

35

DLL-4

GTCCAACTGTG
GCAAACAGC

TGGCTTTTCAC
TGTGTAACCG

148

60

35

GAPDH
-2

ACTAGGCGCTC
ACTGTTCTCT

CAATACGACC
AAATCCGTTGA
CT

99

60

30

2.3.2

Quantitative reverse transcriptase PCR (qRT-PCR)
qRT-PCR was performed using Power SYBR® Green PCR Master Mix and run

using an Applied Biosystems StepOne Plus machine. Gapdh was used for normalization of
qRT-PCR results. Samples were run in triplicate.
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2.4

Protein analysis

2.4.1

Protein extraction and collection.
When cells reached 70-80% confluency plates were rinsed with cold PBS. Cells

were collected in lysis solution composed of RIPA buffer and protease inhibitor and
transferred into Eppendorf tubes where they maintained constant agitation for 30 minutes
at 4˚C. They were then centrifuged at 12000 RPM for 20minutes at 4˚C and the supernatant
was transferred into a new Eppendorf tube.
2.4.2

Protein concentration.
Protein concentrations were measured using Bio-Rad Protein Assay Dye Reagent

Concentrate following manufacturer's protocol. Absorbance was measured at a wavelength
of 595 nm.
2.4.3

Western blots

Protein samples were boiled and loaded into a 4-15% polyacrylamide gel based off of the
Bradford assay results. Proteins were transferred on a Trans-Blot Turbo Mini PVDF
Transfer using the Bio-Rad Trans-Blot Turbo Transfer System. The membranes were then
blocked using a 5% blocking buffer composed of nonfat dry milk and TBST, then probed
overnight with a primary antibody (Table 2-3). The membranes were then washed with
TBST and probed with a secondary antibody for 60 minutes. After being washed, the
membranes were then imaged with Bio-Rad clarity western ECL substrate and analyzed
using ImageJ software.
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Table 2-3: Antibody list
Antibody

Dilution

Company

Catalog #

MED12

1:1000

Bethyl

A3000-774A

Notch1

1:1000

Proteintech

20687-I-AP

Notch3

1:1000

Cell signaling

5276S

GAPDH

1:3000

abcam

Ab9485

abcam

Ab6721

Goat pAb to Rb IgG 1:10000
(HRP)

CHAPTER 3
RESULTS

3.1

Introduction
Stem cells are unique in that they have the ability to differentiate and self-renew.

Human adipose stem cells are a multipotent stem cell that possess therapeutic potential to
treat multiple diseases and to help in regenerative medicine. If we are able to gain a better
understanding of how we can control the fate of hASCs, this will allow stem cells to be
used to their full potential in regenerative medicine. Here we seek to gain an understanding
of hASCs by focusing on the Mediator complex and its effects on Notch signaling.
Mediator is highly conserved in eukaryotic cells and directly controls transcription by
interacting with signaling pathways like Notch.
The Mediator complex plays a vital role in the regulation of cell-type transcription
in eukaryotic cells (Straub, Venigalla and Newman, 2020). There are four modules of the
Mediator complex: the head, middle, tail, and the kinase. Our focus is on the kinase module
that consist of CDK8, Cyclin C, MED12, and MED13 (Park et al., 2018). We are
specifically interested in MED12 and its role in regulating and controlling transcription in
hASCs as MED12 is a critical part of the Mediator complex implicated in a number of
human developmental defects and disease. Similarly, The Notch signaling pathway is an
essential regulatory pathway in development, cell differentiation, proliferation, and
apoptosis (Nueda et al., 2018).
15
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In this chapter I will discuss how MED12 effects Notch1 and Notch3 in hASCs.
We report on the expression and activity of MED12, Notch1, and Notch3 in self-renewing
human adipose stem cells and determine the impact that MED12 knockdown has on Notch1
and Notch3 expression and activity in self-renewing hASC’s. We hypothesized that
MED12 has a critical role in regulating transcription, while Notch signaling has a role in
directing cell fate commitment. We observed that the knockdown of MED12 in hASCs has
no effect on the protein expression of Notch1. We also observed that the knockdown of
Notch3 does reduce the amount of MED12 transcript expressed in hASCs. To date our data
suggests that MED12 has no effect on Notch1 expression but does affect Notch3
expression. In addition, the knockdown of Notch3 directly effects MED12 transcript. This
data indicates a unique role for MED12 and a relationship with Notch3 in regulating cell
state, leading us one step closer to realizing the clinical potential of these cells and using
them in novel cell-based and tissue engineering therapies.
3.2

Results

MED12 KD has no effect on Notch1 in self-renewing hASCs
In order to understand the influence of the Mediator complex, specifically MED12
on the highly conserved Notch signaling pathway we transfected hASCs with MED12
siRNA so that we could observe how the transfections affected Notch1. MED12 levels
were decreased in cell culture via siRNA transfections and the knockdowns were validated
using qRT-PCR and western blot. MED12 transcript was significantly reduced in
comparison to negative controls while there was no significant effect on the levels of
Notch1 transcript (Figure 3-1). In addition, MED12 protein levels were significantly
reduced while there was once again no significant effect on the Notch1 protein levels
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(Figure 3-2). Although both MED12 and Notch1 have a role in determining cell state, this
data suggests that MED12 is not responsible for regulating the transcript and expression of
Notch1.

P value= .0000325

P value= 0.025110258

Figure 3-1: MED12 knockdown leads to decreased Notch1 transcript. MED12
siRNA effectively knockdowns MED12 transcript and diminishes expression of Notch1.
Transcript levels of MED12 (left) and Notch1 (right) in hASCs transfected with MED12
siRNA analyzed via qRT-PCR. There was not a significant reduction in the Notch1
transcript levels. Data was normalized to GAPDH. P values were calculated with T Test,
n=2.

P value= 0.0285528

Figure 3-2: MED12 knockdown has no effect on Notch1 protein levels. Protein
expression levels of hASCs transfected with MED12 siRNA via Western blot. (Left) The
MED12 knockdown was validated while the identification of Notch1 was unsuccessful.
ImageJ data showing the MED12 knockdown Western blot quantified using ImageJ
software. Western blot was normalized to GAPDH. P values were calculated with T Test,
N=2. (Right)
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MED12 KD does affect Notch3 expression in self-renewing hASCs
In continuation of trying to understand the influence of the Mediator complex,
specifically MED12 on the highly conserved Notch signaling pathway hASCs were
transfected with MED12 siRNA so that we could observe how the knockdown of MED12
affected Notch3 expression and activity. MED12 levels were decreased in cell culture via
siRNA transfections and the knockdowns were validated using qRT-PCR and western blot.
MED12 transcript was significantly reduced in comparison to negative controls and there
was also a significant reduction in the Notch3 transcript levels (Figure 3-3). The MED12
protein levels were significantly reduced while there was an increase in full length Notch3
protein, and a decrease in cleaved (activated) Notch3 protein (Figure 3-3)(Figure 3-4).
Granted, we know that MED12 and Notch3 have a role in determining cell state, this data
suggest that MED12 is responsible for regulating the transcript and expression of Notch3.

P value= 0.003754448

Figure 3-3: MED12 knockdown leads to decreased Notch3 transcript and an increase
in full length Notch3 and a decrease in cleaved Notch3. Transcript levels in hASCs
transfected with MED12 siRNA analyzed via qRT-PCR. The MED12 knockdown was
validated (Figure 3-1). There was a significant reduction in the Notch3 transcript levels.
Data was normalized to GAPDH. P values were calculated with T Test, N=2. (Left) Protein
expression levels of hASCs transfected with MED12 siRNA via Western blot. The MED12
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knockdown was validated while the knockdown caused an increase in full length Notch3
and a decrease in cleaved Notch3. (Right)

Figure 3-4: MED12 knockdown effects on Notch3 protein levels. ImageJ analysis of
MED12 knockdown Western blot effects on Notch3. Western blot quantified using ImageJ
software. Western blot was normalized to GAPDH. P values were calculated with T Test,
N=2.

Notch1 KD has no effect on MED12 in self-renewing hASCs
After it was determined that the knockdown of MED12 did not have any significant
effect on Notch1 transcript or protein, results were confirmed by transfecting cells with
Notch1 siRNA to determine if it had any effect on MED12 transcript or protein. Notch1
levels were decreased in cell culture via siRNA transfections and the knockdowns were
validated using qRT-PCR and western blot. Notch1 transcript was significantly reduced in
comparison to negative controls and there was not a significant reduction in the MED12
transcript levels nor protein levels (Figure 3-5)(Figure 3-6). This data is confirmation of
what we had already observed, that although both MED12 and Notch1 have a role in
determining cell state, Notch1 is not responsible for the regulation of MED12 transcript
and protein levels.
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P value= 0.00018

P value= 0.240368323

Figure 3-5: Notch1 knockdown has no effect on MED12 transcript. The Notch1
knockdown was validated. Transcript levels in hASCs transfected with Notch1 siRNA
analyzed via qRT-PCR. There was not a significant reduction in the MED12 transcript
levels. Data was normalized to GAPDH. P values were calculated with T Test, N=2.

Figure 3-6: Notch1 knockdown has no effect on MED12 protein levels. Protein
expression levels of hASCs transfected with Notch1 siRNA via Western blot. MED12 was
not affected by the Notch1 knockdown, while the identification of Notch1 was
unsuccessful

Notch3 KD does affect MED12 in self-renewing hASCs
Since it was determined that the knockdown of MED12 did significantly affect
Notch3 transcript and protein, we completed the transfection of Notch3 to determine if it
had any effect on MED12 transcript or protein. Notch3 levels were decreased in cell culture
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via siRNA transfections and the knockdowns were validated using qRT-PCR and western
blot. Notch3 transcript was significantly reduced in comparison to negative controls and
there was also a significant reduction in the MED12 transcript levels (Figure 3-7). The
Notch3 protein levels were significantly reduced while there was a decrease in MED12
protein levels (Figure 3-8)(Figure 3-9). The data observed shows that Notch3 regulates
MED12 transcript and expression. This data combined with the data found in relation to
MED12 and how it regulates Notch3 transcript and expression shows that MED12 and
Notch3 work together to determine cell fate.

P value= .0000114

P value= 0.003867056

Figure 3-7: Notch3 knockdown leads to reduction in MED12 transcript. Transcript
levels in hASCs transfected with Notch3 siRNA analyzed via qRT- PCR. The Notch3
knockdown was validated. There was a significant reduction in the MED12 transcript
levels. Data was normalized to GAPDH. P values were calculated with T Test, N =2.
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Figure 3-8: Notch3 knockdown leads to reduction in MED12 protein levels. Protein
expression levels of hASCs transfected with Notch3 siRNA via Western blot. The Notch3
knockdown was validated while the Notch3 knockdown had a slight effect on MED12
protein levels causing MED12 protein levels to decrease.

Figure 3-9: Notch3 knockdown leads to reduction in MED12 protein levels. ImageJ
analysis of a Notch3 knockdown effects on MED12. Western blot quantified using ImageJ
software. Western blot was normalized to GAPDH. P values were calculated with T Test,
N=2.

23
MED12 KD effects on Notch signaling conical pathway ligands in self renewing hASCs
The data showed that after a MED12 knockdown in hASCs Notch1 transcript and
protein levels were not affected, while Notch3 transcript and protein levels were
significantly affected. The next step was to take a more focused look at the Notch signaling
pathway and to see which of the Notch signaling conical pathway ligands, specifically
Jagged1 and Jagged2, were affected by a MED12 knockdown. MED12 levels were
decreased in cell culture via siRNA transfections and the knockdowns were validated using
qRT-PCR. MED12 transcript was significantly reduced in comparison to negative controls
and there was a slight increase in Jagged1 and Jagged2 transcript, but neither were
significantly affected (Figure 3-10). This data suggests that neither Jagged1 nor Jagged2
contributes to MED12 role in determining cell state.

P value= 0.106797

P value= 0.371344063

Figure 3-10: MED12 knockdown leads to increase in both Jagged1 and Jagged2
transcript. Transcript expression levels of hASCs transfected with MED12 siRNA
analyzed via qRT-PCR. The MED12 knockdown was validated while Jagged1 and Jagged2
expression levels slightly increased but neither were significant. Data was normalized to
GAPDH.
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3.3

Conclusion
After completing the knockdown of MED12 in hASCs and observing both Notch1

and Notch3 transcript expression and protein levels, the results indicate that Notch1 does
not have an active role in keeping the cells in the self-renewing state. The transcript levels
and protein levels were low in the negative control samples and were not significantly
affected by the MED12 knockdown. However, the data suggest that after the MED12
knockdown, Notch3 transcript and protein levels were significantly affected. The transcript
expression data shows that Notch3 was reduced after the MED12 knockdown. The protein
levels of Notch3 after the MED12 knockdown showed that full length Notch3 increased
while cleaved or activated Notch3 levels decreased. When observing how the canonical
pathway, specifically Jagged1 and Jagged2, of the Notch signaling pathway was affected
by the MED12 knockdown, the data shows that neither Jagged1 nor Jagged2 transcript was
significantly affected although we did see increases in the transcript.

CHAPTER 4
CONCLUSIONS AND FUTURE WORK

4.1

Conclusions

At the start of our research, we hypothesized that MED12 has a critical role in
regulating transcription, and directly effects the Notch signaling pathway and therefore cell
fate commitment. After completing countless experiments where either siRNAs targeting
MED12, Notch1, or Notch3 were transfected into hASCs, the data suggest that Notch1
does not have an active role in directing cell fate. Both Notch1 transcript (Figure 3-1) and
protein levels (Figure 3-2)were unaffected by the MED12 knockdown and when Notch1
was knocked down, neither MED12 transcript (Figure 3-5) nor protein levels (Figure 3-6
Figure 3-6) were affected. This suggest that Notch1 does not have an active role in
regulating these mechanisms and may not have a role in hASC self-renewal. Next, we
observed how Notch3 was affected by the MED12 knockdown. We were able to show that
Notch3 transcript levels (Figure 3-3) were significantly reduced, while the levels of full
length Notch3 protein (Figure 3-4) increased and the cleaved (activated) form of Notch3
decreased. This observation suggests that MED12 has an active role in the regulation and
activation of Notch3 in hASCs. The influence of diminished expression of MED12 on
Notch3 lead us to knockdown Notch3 to determine what impact that might have on MED12
expression. These results showed that after a Notch3 knockdown in hASCs, MED12
transcript were significantly reduced (Figure 3-7) and protein levels appeared to follow a
25
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similar trend (Figure 3-8, Figure 3-9). This data does not completely support our initial
hypothesis that that MED12 has a critical role in regulating transcription by directly
influencing the Notch signaling pathway, but it does suggest that MED12 and Notch3 work
together in some way to regulate hASCs self-renewal.
With the data that we have accumulated through multiple assays, we have
contributed critical information that will aid in moving closer to an ability to control and
manipulate hASCs for research and clinical applications. To date there is little literature on
the relationship between Notch signaling and the Mediator complex. Some more recently
studies did observe the effects on Notch1 after MED12 was mutated in chronic
lymphocytic leukemia cells but other than that one instance, there is no literature linking
the two (Wu et al., 2017). What I have completed while working in the lab starts to fill a
much-needed gap in the literature that links Notch signaling and the Mediator complex in
regulating hASC self-renewal.
We are currently in the process of furthering this research by investigating how the
canonical Notch transmembrane Delta-like ligands are affected by the MED12
knockdown. We have started this work and have qRT-PCR data where we observe changes
in Jagged1 and Jagged 2 expression following a MED12 knockdown (Figure 3-10), but
we have yet to observe how DLL1, DDL3, and DDL4 transcript are affected by the MED12
knockdown. If we determine that one of the five Notch ligands is significantly affected by
the MED12 knockdown, either increased or decreased, the next objective will be to
knockdown that specific ligand and work to determine the influence of that ligand on
MED12, Notch1, or Notch3 expression and hASC self-renewal. We can also observe the
non-canonical Notch signaling pathway by knocking down MED12 and determining the
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potential role of non-canonical ligands, specifically DLK1 and DLK2, in controlling hASC
self-renewal. Finally, in order to determine the global changes in gene expression following
the knockdown of any one of these critical transcriptional regulatory, we could perform
microarray analysis or RNA-Seq. Understanding of how we can control the fate of stem
cells, will allow manipulation so that stem cells may be used to their full potential in
regenerative medicine.
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